Catalyst Wire Dossier Catalyst Wire Dossier

SAVELLA

milnacipran hydrochloride · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

43 regulatory and trial events tracked for SAVELLA, covering 2007-12-24 to 2025-09-10. Get the full timeline:

Most recent: FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)

See pricing